| Literature DB >> 27766382 |
L-C Horn1, C E Brambs2, R Handzel3, S Lax4, I Sändig5, D Schmidt6, K Schierle5.
Abstract
The World Health Organization (WHO) classification from 2014 differentiates between different subtypes of mucinous adenocarcinoma of the uterine cervix. A gastric subtype was recently described that showed no association with high-risk human papillomavirus (HPV) infections, has a poor prognosis, is mainly diagnosed in women of Asian origin and can occur in patients with Peutz-Jeghers syndrome. Although no clear grading system has been recommended in the WHO classification, it is likely that grading of adenocarcinomas of the uterine cervix will partly be based on the different patterns of invasion. Deep stromal infiltration of macroinvasive carcinomas is defined as an infiltration of >66 % of the cervical stroma. In the near future a maximum tumor size of 2 cm could act as a discriminator for planning of less radical surgery. Parameters of the histopathological report that are relevant for the prognostic assessment as well as the choice of adjuvant treatment and function as quality indicators during certification are described. The histological type of an adenocarcinoma alone is of no predictive or prognostic relevance for patients undergoing primary surgical treatment, neoadjuvant chemotherapy, combined chemo-radiotherapy or treatment with angiogenesis inhibitors. Currently, molecular parameters and biomarkers are of no relevance.Entities:
Keywords: Adenocarcinoma; Biomarkers; Grading; Molecular pathology; Quality indicators
Mesh:
Substances:
Year: 2016 PMID: 27766382 DOI: 10.1007/s00292-016-0232-2
Source DB: PubMed Journal: Pathologe ISSN: 0172-8113 Impact factor: 1.011